TwinStrand Biosciences
Business Services · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3131 Elliott Ave Ste 750, Seattle, Washi...Phone Number
(206) 202-8946Website
www.twinstrandbio.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About TwinStrand Biosciences
TwinStrand Biosciences is leading the way in identifying ultra-low frequency genomic variants that are undetectable by conventional methods. The company's highly sensitive and specific Duplex Sequencing technology delivers clearer insights to researchers and clinicians in applications ranging from residual cancer detection to genetic toxicology. This data can inform critical decisions in clinical medicine, public health, and other fields of science on a faster timescale, where actions are most impactful. TwinStrand's scientist-leaders have authored more than two dozen peer-reviewed articles using Duplex Sequencing Technology and have developed a portfolio of more than 100 patents and patent applications. The company has partnered with pharmaceutical companies, academic centers, clinical research networks and federal regulatory agencies to bring high precision genomics to the forefront of their science. The company was founded in 2015 out of Seattle, Washington.Explore more
TwinStrand Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TwinStrand Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if TwinStrand Biosciences has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once TwinStrand Biosciences has new funding data
Click to see if TwinStrand Biosciences had a recent Job posting/layoffs
TwinStrand Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if TwinStrand Biosciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at TwinStrand Biosciences
Product Launch: Get notified when TwinStrand Biosciences launches new products
Earning: See what the market has to say on TwinStrand Biosciences recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined TwinStrand Biosciences as Masked Content
Find more new buyers
Compare Similar Companies to TwinStrand Biosciences
Compare insights from companies similar to TwinStrand Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
TwinStrand Biosciences
$10.6M
11-50
Private
$73.6M
2015
JB
Jana BrattonDirector, Strategic Initiatives & Chief of Staff
Company Profile Activity
Activity Insights
TwinStrand Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
TwinStrand Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about TwinStrand Biosciences.
TwinStrand Biosciences financials insights
Gather financial insights about TwinStrand Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Debt
$1.9M
2017
Private Equity
$5.3M
2020
Series A
$16M
Debt
$350K
2021
Series B
$50M
TwinStrand Biosciences Tech Stack
A closer look at the technologies used by TwinStrand Biosciences
See more technologies
Most Recent Scoops
Project
Intellectual Property, Lawsuits, Legal Affairs
Funding
Project
Spending/Investment
Project
Intellectual Property, Lawsuits, Legal Affairs
Open Position
Open Position
TwinStrand Biosciences News & Media
Scantox Acquires DuplexSeq™ Nonclinical Genomics Safety Business from TwinStrand Biosciences
Global expansion of advanced mutagenesis testing services supports regulatory genetic toxicology and next-generation genomic safety assessment EJBY, Denmark, Feb. 26, 2026 /PRNewswire/ -- Scantox Group today announced it has acquired the nonclinical genomic safety business of TwinStrand...Scantox Acquires DuplexSeq™ Nonclinical Genomics Safety Business from TwinStrand Biosciences
Global expansion of advanced mutagenesis testing services supports regulatory genetic toxicology and next-generation genomic safety assessment EJBY, Denmark, Feb. 26, 2026 /PRNewswire/ -- Scantox Group today announced it has acquired the nonclinical genomic safety business of TwinStrand...TwinStrand Biosciences Initiates Regulatory Approval Process for Duplex Sequencing Mutagenesis Assays with OECD
OECD approves application to initiate regulatory acceptance process for ecNGS technology, an improved method for mutagenesis testing. Duplex Sequencing ecNGS mutagenesis assays are poised to set benchmark for safety assessment in diverse sectors including pharmaceuticals, food, chemicals,...Federal Jury Finds Guardant Health Willfully Infringes University of Washington Duplex Sequencing Patents Exclusively Licensed to TwinStrand Biosciences, Inc., Awards $83.4M in Damages; PTAB Rejects Invalidity Arguments on UW Patents
Federal jury finds Guardant Health, GH (NASDAQ), willfully infringes University of Washington duplex sequencing patents exclusively licensed to TwinStrand Biosciences, Inc. and awards $ 83.4M in damages. Jury finds FDA-approved product Guardant 360® CDx infringes the University of...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding TwinStrand Biosciences
Sign Up For FreeTo access detailed company insights
TwinStrand Biosciences is leading the way in identifying ultra-low frequency genomic variants that are undetectable by conventional methods. The company's highly sensitive and specific Duplex Sequencing technology delivers clearer insights to researchers and clinicians in applications ranging from residual cancer detection to genetic toxicology. Th... Read More
